Oliver Schoor
Immatics Biotechnologies (Germany)(DE)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Research and Treatments, Immunotherapy and Immune Responses, Biomedical Ethics and Regulation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Actively personalized vaccination trial for newly diagnosed glioblastoma(2018)910 cited
- → Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival(2012)780 cited
- → Autophagy promotes MHC class II presentation of peptides from intracellular source proteins(2005)630 cited
- → Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding(2005)351 cited
- → Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy(2012)200 cited
- Integrated functional genomics approach for the design of patient-individual antitumor vaccines.(2002)
- → A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma(2016)162 cited
- → RNA editing derived epitopes function as cancer antigens to elicit immune responses(2018)153 cited
- → Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface(2006)128 cited
- → Autophagy in innate and adaptive immunity against intracellular pathogens(2006)123 cited